Pharmagroup Int. And Fluvera: When Subsidiary Governance Means Losing Competitive Ground Harvard Case Solution & Analysis

IMD-3-1706 © 2006
Steger, Ulrich; Brellochs, Jochen; Amann, Wolfgang

The item was developed by a United States novel start up; that had actually initially formed a tactical Joint Venture with Pharmagroup; however was then more and more built-in into the group since of troubles in R&D that Pharmagroup was not able to conquer and administer. Now; R&D takes location in a totally owned United States subsidiary however Pharmagroup is still not able to make substantial development with the existing governance system.

The knowing goal is to understand the value of subsidiary governance and its company measurement in international groups; to recognize vital issues and triggers in the setting and to create a subsidiary governance system for the United States operations that causes prompt and effective conclusion of advancement and market commencement.

Pharmagroup Int. And Fluvera When Subsidiary Governance Means Losing Competitive Ground case study solution

Subjects: Corporate Governance ; Subsidiaries ; Joint Ventures ; Post-acquisition integration ; Pharmaceutical Industry
Settings: Europe; US; Pharmaceutical; € 4 billion turnover; 21;000 employees; 1998-2006

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.